Collagenous colitis
Induction of remission/symptomatic relief of chronic diarrhoea in collagenous colitis
Budesonide
Budenofalk 3mg gastro-resistant capsules
3mg three times daily for 8 weeks, reduce dose for last two weeks of treatment.
Budenofalk 9mg gastro-resistant granules sachets
9mg in the morning for 8 weeks, reduce dose for last two weeks of treatment. Granules should be placed on the tongue and swallowed whole with plenty of liquid.
Prescribing Notes:
- Treatment with oral budesonide should only be commenced in patients with biopsy proven collagenous colitis on advice of specialist gastroenterologist.
- The granule formulation may be of benefit in patients with swallowing difficulties and also when once daily administration is desirable.
- Treatment should not be stopped abruptly and should be tapered down over the last 2 weeks. A suggested regimen for the capsule formulation is to reduce to 3mg twice daily for one week, then 3mg once daily for one week. For the granule formulation, administration can be reduced to alternate days for the last two weeks of treatment.
History Notes
15/12/2021
East Region Formulary content agreed.